文献速递乳房整形与再造美容整形

局部浸润麻醉与超声引导胸肌(PEC1)+前锯肌平面(SAP)阻滞在初次胸肌下隆乳术患者麻醉后监护室疼痛控制中的比较

Local Infiltration Anesthesia Versus Ultrasound-Guided Pectoralis (PEC1) + Serratus Anterior Plane (SAP) Blocks on Postanesthetic Care Unit Pain Control in Patients Undergoing Primary Submuscular Augmentation Mammoplasty.
PubMed 文献 · Ann Plast Surg · 2024-01-01

这项回顾性队列研究比较了两位整形外科医生在2018年至2022年间对初次胸肌下隆乳术患者采用的两种麻醉方式。组2接受超声引导PEC1+SAP阻滞,组1接受盲法局部浸润麻醉。组2在麻醉后监护室的阿片类药物用量显著更低(3.04 MME vs 4.52 MME,P=0.041),停留时间更短(70.13分钟 vs 80.38分钟,P=0.008),而出院时疼痛评分、手术时间和假体大小无显著差异。

要点

  • 超声引导PEC1+SAP阻滞组麻醉后监护室阿片类药物用量为3.04 MME,低于局部浸润麻醉组的4.52 MME(P=0.041)。
  • 超声引导PEC1+SAP阻滞组麻醉后监护室停留时间为70.13分钟,短于局部浸润麻醉组的80.38分钟(P=0.008)。
  • 两组出院时疼痛评分、手术时间和假体大小无显著差异。

核心结论

  • 由外科医生在术中实施的超声引导PEC1+SAP阻滞将麻醉后监护室的阿片类药物用量降低了33%,并将麻醉后监护室停留时间缩短了13%,同时患者疼痛评分和手术时间相似。

研究设计与样本

  • 回顾性机构审查委员会批准的队列研究,比较同一认证门诊手术中心两位整形外科医生在2018年至2022年间的不同实践。
  • 组1接受术中盲法局部浸润麻醉,组2接受由外科医生在术中实施的超声引导PEC1+SAP阻滞。
  • 排除接受除初次胸肌下隆乳术以外任何手术的患者,每组60例符合纳入标准,共120例患者。

主要发现

  • 组2在麻醉后监护室的平均吗啡毫克当量需求显著低于组1(3.04 MME vs 4.52 MME,P=0.041)。
  • 组2的平均麻醉后监护室停留时间显著短于组1(70.13分钟 vs 80.38分钟,P=0.008)。
  • 两组出院时疼痛水平、手术时间或假体大小无显著差异。
  • 研究组间彼此相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Ultrasound-guided regional field blocks are not widely used in outpatient plastic surgeries. The efficacy of truncal blocks (PEC1 + SAP) has not been established in plastic surgery. The purpose of this study was to analyze the outcomes of these newer anesthetic techniques compared with traditional blind local anesthetic infiltration in patients undergoing breast augmentation. METHODS: This retrospective institutional review board-approved cohort study compared the outcomes of the different practices of 2 plastic surgeons at the same accredited outpatient surgery center between 2018 and 2022. Group 1 received an intraoperative blind local infiltration anesthetic. Group 2 underwent surgeon-led, intraoperative, ultrasound-guided PEC1 (Pectoralis 1) + SAP (serratus anterior plane) blocks. Patients who underwent any procedure other than primary submuscular augmentation mammoplasty were excluded from the study. The outcomes measured included operative time, opioid utilization in morphine milligram equivalents (MME), pain level at discharge, and time spent in the post anesthetic care unit (PACU). RESULTS: Sixty patients met the inclusion criteria for each group for a total of 120 patients. The study groups were similar to each other. Patients receiving PEC1 + SAP blocks (group 2) had significantly lower average MME requirements in the PACU (3.04 MME vs 4.52 MME, P = 0.041) and required a shorter average PACU stay (70.13 minutes vs 80.38 minutes, P = 0.008). There were no significant differences in the pain level at discharge, operative time, or implant size between the 2 groups. CONCLUSIONS: Surgeon-led, intraoperative, ultrasound-guided PEC1 + SAP blocks significantly decreased opioid utilization in the PACU by 33% and patient time in the PACU by 13%, while achieving similar patient pain scores and operating times.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Heffern JN, Puyana S, Hajebian HH, et al. Local Infiltration Anesthesia Versus Ultrasound-Guided Pectoralis (PEC1) + Serratus Anterior Plane (SAP) Blocks on Postanesthetic Care Unit Pain Control in Patients Undergoing Primary Submuscular Augmentation Mammoplasty. Ann Plast Surg. 2024. PMID: 38857002. doi:10.1097/SAP.0000000000003948

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。